January/February 2014 - Volume 37 - Issue 1
pp: 1-39

Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study

Emre, Murat; Poewe, Werner; De Deyn, Peter Paul; More

Clinical Neuropharmacology. 37(1):9-16, January/February 2014.

Reduction in the Free Radical Status and Clinical Benefit of Repeated Intrathecal Triamcinolone Acetonide Application in Patients With Progressive Multiple Sclerosis

Müller, Thomas; Herrling, Thomas; Lütge, Sven; More

Clinical Neuropharmacology. 37(1):22-25, January/February 2014.